Sun Pharmaceutical Industries Ltd.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed that the Analyst/Institutional Investor Meeting with the Company ‘Bank of America Healthcare Tour’ held on 3-Mar-2023 in Sun House, Mumbai. The company will not be disclosing any Unpublished Price Sensitive Information (UPSI) at these meetings.

The above information is a part of company’s filings submitted to BSE.